Literature DB >> 7894095

Effects of various growth factors and histamine on cultured keloid fibroblasts.

K Kikuchi1, T Kadono, K Takehara.   

Abstract

OBJECTIVE AND METHODS: We investigated the effects of several growth factors on [3H]thymidine incorporation and procollagen type I carboxyterminal propeptide (P1CP) production, which reflects type I collagen metabolism, in keloid and normal fibroblasts.
RESULTS: Six fibroblast cell strains, derived from keloid or normal skin, exhibited similar growth responses to platelet-derived growth factor, transforming growth factor beta 1 (TGF-beta 1), gamma-interferon (gamma-IFN) and histamine. In contrast, keloid fibroblasts showed significantly greater growth response to epidermal growth factor (EGF) than normal fibroblasts. P1CP production was 4.4 times higher in 6 strains of keloid fibroblasts than in 6 controls. Treatment with gamma-IFN (100 U/ml) decreased P1CP production in both groups; the effect was significantly greater in keloid fibroblasts. TGF-beta 1 treatment upregulated P1CP production in both groups. Treatment with histamine increased P1CP production in keloid fibroblasts, although it did not change that in the controls.
CONCLUSION: EGF and histamine may play some role in the development of keloids.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7894095     DOI: 10.1159/000246625

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  10 in total

1.  Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance.

Authors:  T Chodon; T Sugihara; H H Igawa; E Funayama; H Furukawa
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

2.  Effect of mitomycin on normal dermal fibroblast and HaCat cell: an in vitro study.

Authors:  Yao-wen Wang; Ji-hao Ren; Kun Xia; Shu-hui Wang; Tuan-fang Yin; Ding-hua Xie; Li-hua Li
Journal:  J Zhejiang Univ Sci B       Date:  2012-12       Impact factor: 3.066

3.  Histamine-stimulated expression of insulin-like growth factors in human glioma cells.

Authors:  L T Van der Ven; S C Van Buul-Offers; T Gloudemans; P J Roholl; J S Sussenbach; W Den Otter
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 4.  New approach to the understanding of keloid: psychoneuroimmune-endocrine aspects.

Authors:  Bernardo Hochman; Felipe Contoli Isoldi; Fabianne Furtado; Lydia Masako Ferreira
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-02-10

5.  Management of keloid scars: noninvasive and invasive treatments.

Authors:  Sang Wha Kim
Journal:  Arch Plast Surg       Date:  2021-03-15

Review 6.  Anti-Inflammatory, Antioxidant, and Skin Regenerative Potential of Secondary Metabolites from Plants of the Brassicaceae Family: A Systematic Review of In Vitro and In Vivo Preclinical Evidence (Biological Activities Brassicaceae Skin Diseases).

Authors:  Patricia da Silva Mattosinhos; Mariáurea Matias Sarandy; Rômulo Dias Novaes; Debora Esposito; Reggiani Vilela Gonçalves
Journal:  Antioxidants (Basel)       Date:  2022-07-10

7.  The Expression of Toll-Like Receptors (TLRs) in Cultured Human Skin Fibroblast is Modulated by Histamine.

Authors:  Sujeong Jang; Jong-Sung Park; Young-Ho Won; Sook-Jung Yun; Seong-Jin Kim
Journal:  Chonnam Med J       Date:  2012-04-26

8.  Phenotypic differences between dermal fibroblasts from different body sites determine their responses to tension and TGFbeta1.

Authors:  Constantin C Chipev; Marcia Simon
Journal:  BMC Dermatol       Date:  2002-11-21

9.  Proteomic profiling reveals upregulated protein expression of hsp70 in keloids.

Authors:  Ju Hee Lee; Jung U Shin; Inhee Jung; Hemin Lee; Dong Kyun Rah; Jin Young Jung; Won Jai Lee
Journal:  Biomed Res Int       Date:  2013-10-24       Impact factor: 3.411

10.  MicroRNA-184 Promotes Proliferation and Inhibits Apoptosis in HaCaT Cells: An In Vitro Study.

Authors:  Xiaodong Bi; Yu Cao; Rixin Chen; Chengyin Liu; Jinghong Chen; Dongfang Min
Journal:  Med Sci Monit       Date:  2016-08-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.